Hualan Biological Bacterin Inc.
SZSE:301207.SZ
27.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,127.812 | 2,410.428 | 1,825.641 | 1,829.814 | 2,426.329 | 1,048.988 | 802.738 | 284.911 |
| Cost of Revenue
| 212.559 | 287.098 | 217.451 | 220.761 | 257.939 | 161.006 | 126.873 | 87.854 |
| Gross Profit
| 915.254 | 2,123.331 | 1,608.189 | 1,609.053 | 2,168.39 | 887.982 | 675.865 | 197.057 |
| Gross Profit Ratio
| 0.812 | 0.881 | 0.881 | 0.879 | 0.894 | 0.847 | 0.842 | 0.692 |
| Reseach & Development Expenses
| 162.64 | 91.108 | 134.64 | 144.128 | 110.937 | 73.042 | 52.977 | 64.021 |
| General & Administrative Expenses
| 58.541 | 45.475 | 9.316 | 25.648 | -83.103 | -89.236 | -81.566 | 1.446 |
| Selling & Marketing Expenses
| 492.957 | 941.295 | 680.634 | 582.968 | 865.257 | 306.086 | 337.341 | 187.801 |
| SG&A
| 551.498 | 986.77 | 689.95 | 608.616 | 782.154 | 216.85 | 255.775 | 189.248 |
| Other Expenses
| -13.741 | 35.395 | -3.155 | -1.227 | 1.908 | -1.27 | 0.932 | 0.968 |
| Operating Expenses
| 700.398 | 1,113.273 | 855.962 | 793.887 | 1,003.86 | 369.092 | 320.845 | 265.512 |
| Operating Income
| 214.856 | 1,010.057 | 592.634 | 706.976 | 1,074.09 | 432.041 | 299.802 | -100.525 |
| Operating Income Ratio
| 0.191 | 0.419 | 0.325 | 0.386 | 0.443 | 0.412 | 0.373 | -0.353 |
| Total Other Income Expenses Net
| -0.31 | -3.176 | -3.155 | -1.227 | -0.036 | 0.033 | 1.548 | 19.259 |
| Income Before Tax
| 214.546 | 1,006.881 | 589.479 | 705.749 | 1,074.054 | 432.075 | 301.35 | -99.557 |
| Income Before Tax Ratio
| 0.19 | 0.418 | 0.323 | 0.386 | 0.443 | 0.412 | 0.375 | -0.349 |
| Income Tax Expense
| 9.03 | 146.913 | 69.844 | 84.777 | 149.145 | 56.777 | 31.202 | -22.676 |
| Net Income
| 205.515 | 859.969 | 519.635 | 620.972 | 924.909 | 375.298 | 270.148 | -76.882 |
| Net Income Ratio
| 0.182 | 0.357 | 0.285 | 0.339 | 0.381 | 0.358 | 0.337 | -0.27 |
| EPS
| 0.34 | 1.43 | 0.87 | 1.03 | 1.54 | 0.63 | 0.5 | -0.14 |
| EPS Diluted
| 0.34 | 1.43 | 0.87 | 1.03 | 1.54 | 0.63 | 0.5 | -0.14 |
| EBITDA
| 361.027 | 1,157.927 | 741.883 | 789.735 | 1,117.127 | 444.044 | 306.255 | 12.217 |
| EBITDA Ratio
| 0.32 | 0.48 | 0.406 | 0.432 | 0.46 | 0.423 | 0.382 | 0.043 |